Drug Combinatorial Platform Services
17 services found
Manufactured by:Oval Medical Technologies Ltd. based inBeach Drive, UNITED KINGDOM
Oval’s philosophy is to design platforms to be customisable for specific patient needs. Going deeper than the immediate cognitive and physical need when delivering a drug, we look at each patient group’s emotional needs in depth to develop devices that work as part of their ...
Manufactured by:Alfa Chemistry based inNY, NEW YORK (USA)
Drug Research Service Platforms: Due to Alfa Chemistry's deeply ingrained research and development capabilities, we have been able to advance technologically in both research and development. In addition, we have been able to provide an integrated service platform for our customers' novel medication development ...
by:SilcsBio, LLC based inBaltimore, MARYLAND (USA)
Guess work in drug discovery can be costly and time consuming. Our team is here to remove that for you. With us, your team ...
Manufactured by:PharmAbcine Inc. based inYuseong-gu, SOUTH KOREA
The dual target antibody platform technology of PharmAbcine is based on the fully human antibody candidates selected from HuPhage biopanning process. Depending on antigen presentation patterns on target cell types and the related drug MOA, various bispecific platforms (DIG-body, PIG-body and TIG-body) are adopted in our antibody engineering strategy. Currently, immuno-oncology assets like ...
Manufactured by:IDT Biologika based inDessau-Rosslau, GERMANY
As one of the world’s leading CDMOs for vaccines, gene and immune therapeutics, and other biologics, IDT Biologika has a wealth of experience in the biological processes and technologies used to produce Viral Vaccines, Viral Vectors, and Oncolytic ...
Manufactured by:Meda BioTech, Inc. based inWest Berlin, NEW JERSEY (USA)
Meda's Hybrid-Naiioeiigiiieeriiig™ drug delivery platform generates more commercial opportunities than we can pursue independently. Strategic partnering is thereforea critical component of our ability to advance Meda's novel therapeutics programs into clinical developmentand onto the ...
Distributed by:Avicanna Inc. based inToronto, ONTARIO (CANADA)
Advanced scientific platform for drug delivery, pre-clinical and clinical development. Team of 10+ scientists, deploying optimized proprietary methodologies in extraction, formulation development, analytical testing, pre-clinical models, and clinical development. Comprehensive IP portfolio across all platforms that has led to the development of 20+ proprietary commercial products. R&D ...
Manufactured by:HemoShear Therapeutics, Inc. based inCharlottesville, VIRGINIA (USA)
Using our powerful REVEAL-TxTM drug discovery platform, our scientists are identifying and validating promising approaches to develop novel treatments aiming to extend and improve the quality of life of patients with rare diseases. In our most advanced program, the company is conducting a phase 2 clinical trial of HST5040, an oral small molecule investigational drug for the treatment of patients ...
by:Strateos Inc. based inMenlo Park, CALIFORNIA (USA)
Miniaturization is key to facilitating higher throughput, increasing reliability and accuracy and reducing costs for screening large compound libraries. We have a solid track record in miniaturizing challenging assays to 384- and 1536-well formats for medium to Ultra-High-Throughput Screening (uHTS). Strateos’ smart labs collectively span over 14K sqft and are composed of automated ...
Manufactured by:Lupin Limited based inMumbai, INDIA
Lupin operates in a highly competitive, demanding, dynamic and diverse markets, in which we need to continuously distinguish ourselves from our peers and competitions through differentiated products. We consider research in advanced drug delivery technologies as the cradle for ideas and innovations for the development of high entry barrier products in inhalation, injectable, ophthalmic and oral ...
Manufactured by:Synbio Technologies LLC based in, NEW JERSEY (USA)
Hybridoma technology features the effective usage of innate functions of both immune and cancer cells to generate monoclonal antibodies (mAbs). The resulting hybridoma cell lines are produced to combat specific antigens of interest. Such technology has forged remarkable new approaches toward therapeutic mAb discovery, as well as disease diagnosis and ...
by:Indivumed GmbH based inHamburg, GERMANY
Once a target is identified the various effects of the drug can be measured. This involves all read-outs we use during the biomarker validation but instead of looking at the effect of various candidates we focus on one component. As the tumor microenvironment can play an important role we focus especially on test methods involving fresh tissue. ...
Manufactured by:Neuron Bio based inGranada, SPAIN
Neuron Biolabs develops biosolutions for application in the pharmaceutical and agri-food industries through its specialised divisions. The Pharma division is dedicated fundamentally to the search for preventative drugs and treatments for neurodegenerative diseases, particularly Alzheimer’s disease. The Diagnostic division develops tools and biomarkers for the diagnosis of diseases of the ...
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
Active Pharmaceutical Ingredients (APIs) are substances or mixtures employed in the production of drugs. They have pharmacological effects or directly contribute to diagnosing, treating, mitigating symptoms, controlling, or preventing diseases, in addition to influencing the structure or function of the body. ...
by:NOVO Engineering based inVista, CALIFORNIA (USA)
Device Types: On-body injectors; Autoinjectors; Pen injectors; Prefilled syringes; Insulin pumps; Microneedle array devices; Smart pills; Electroporation-enabled ...
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
Drug screening refers to the evaluated process of substances (samples) potentially used as drugs, assessing their biological activity, pharmacological effects, and therapeutic value through appropriate methods. This process encompasses biochemical and cellular levels of screening, divided into high-throughput screening (HTS) and virtual ...
Manufactured by:XILIS, Inc. based inDurham, NORTH CAROLINA (USA)
Xilis’ rapid and scalable patient-derived MicroOrganoSphere (MOS) technology platform enhances precision medicine and pharmaceutical drug discovery and development. Compared to conventional patient-derived models, MOS provides faster, higher-throughput, and greater cost savings, as well as more predictive and accurate results. MOS can be used in large-scale pharmacogenomic studies that are ...